Thermo Fisher Scientific (TMO) Holder Bradley Foster & Sargent Lifted Holding; First Fiduciary Investment Counsel Cut Its Procter & Gamble (PG) Holding by $569,380; Market Valuation Rose

Thermo Fisher Scientific Inc. (NYSE:TMO) Logo

Bradley Foster & Sargent Inc increased its stake in Thermo Fisher Scientific (TMO) by 21.51% based on its latest 2018Q3 regulatory filing with the SEC. Bradley Foster & Sargent Inc bought 43,039 shares as the company’s stock declined 0.05% with the market. The institutional investor held 243,159 shares of the industrial machinery and components company at the end of 2018Q3, valued at $59.35 million, up from 200,120 at the end of the previous reported quarter. Bradley Foster & Sargent Inc who had been investing in Thermo Fisher Scientific for a number of months, seems to be bullish on the $96.16 billion market cap company. The stock increased 1.04% or $2.47 during the last trading session, reaching $238.86. About 1.87 million shares traded. Thermo Fisher Scientific Inc. (NYSE:TMO) has risen 27.72% since January 10, 2018 and is uptrending. It has outperformed by 27.72% the S&P500. Some Historical TMO News: 13/03/2018 – Thermo Fisher Scientific Showcases New Solutions for Accelerating, lnnovating and Enhancing Productivity in the Fab and Lab at SEMICON China 2018; 01/05/2018 – SPECTRUM, THERMO FISHER IN DIAGNOSTIC PARTNERSHIP; 03/04/2018 – Rapid Mycoplasma Testing Method Now Accepted by Regulators for QA/QC and Lot Release; 15/03/2018 – Thermo Fisher Scientific Named lndustryWeek Best Plants Award Winner 2017; 15/05/2018 – Omega Adds Thermo Fisher, Exits Zynga, Cuts Shire: 13F; 13/04/2018 – Global Gas Analyzer Market Forecast to 2023 with ABB Group, Emerson Electric, General Electric, Figaro Engineering, and Thermo Fishers Scientific Dominating – ResearchAndMarkets.com; 28/03/2018 – Biocept and Thermo Fisher Scientific Enter Into Technology and Comml Collaboration; 22/03/2018 – Dunes Point Capital, LP Announces the Acquisition of Thermo-Tech Windows, LLC; 16/03/2018 – Thermo Fisher Scientific Announces Plans to Build State-of-the-Art Pharma Services Facility in Rheinfelden (Baden) Germany; 25/04/2018 – Parent Co Will Be Renamed Thermo Companies, Inc., and Its Stk Will Continue to Trade Publicly

First Fiduciary Investment Counsel Inc decreased its stake in Procter & Gamble (PG) by 3.97% based on its latest 2018Q3 regulatory filing with the SEC. First Fiduciary Investment Counsel Inc sold 6,860 shares as the company’s stock rose 12.93% while stock markets declined. The institutional investor held 165,775 shares of the package goods and cosmetics company at the end of 2018Q3, valued at $13.80M, down from 172,635 at the end of the previous reported quarter. First Fiduciary Investment Counsel Inc who had been investing in Procter & Gamble for a number of months, seems to be less bullish one the $227.14B market cap company. The stock increased 0.24% or $0.22 during the last trading session, reaching $91.17. About 10.48 million shares traded. The Procter & Gamble Company (NYSE:PG) has risen 3.25% since January 10, 2018 and is uptrending. It has outperformed by 3.25% the S&P500. Some Historical PG News: 13/03/2018 – P&G – RESOLVED ITS PATENT INFRINGEMENT DISPUTE WITH RANIR, LLC REGARDING RANIR’S TOOTH WHITENING STRIP PRODUCTS IN UNITED STATES AND CANADA; 12/05/2018 – Bleacher Report: Derrick Rose Rumors: Timberwolves Interested in Bringing PG Back in Free Agency; 09/05/2018 – SIEMENS BOARD MEMBER LISA DAVIS SAYS EXPECTS PG FY2018 REVENUE TO BE SUBSTANTIALLY LOWER THAN 2017; 06/03/2018 – MEDIA-P&G to cut ad agency spending by $1.25 bln over next 3 years – FT; 25/05/2018 – PG ELECTROPLAST LTD PGEL.NS – MARCH QTR REVENUE FROM OPS 1.17 BLN RUPEES VS 1.34 BLN RUPEES YR AGO; 19/04/2018 – S&PGRBULLETIN: P&G RTGS UNCHANGED BY TEVA EXIT, OTC ACQSTNS; 11/04/2018 – Vicks® ZzzQuil™ Expands Offering with New Vicks ZzzQuil PURE Zzzs™ Melatonin Gummies; 23/05/2018 – P&G – SETTLEMENT DATE FOR SECURITIES TENDERED AT/PRIOR TO EARLY TENDER DEADLINE & ACCEPTED FOR PURCHASE IS EXPECTED TO BE MAY 25, 2018; 18/05/2018 – Kimberly-Clark, Johnson & Johnson’s, Procter & Gamble and Edgewell Personal Care have reported sale declines in their baby businesses this year; 08/05/2018 – Forum Systems Named Gold Winner in Info Security PG’s 2018 Global Excellence Awards®

Since August 13, 2018, it had 0 insider purchases, and 58 sales for $98.11 million activity. The insider Keith R. Alexandra sold 1,463 shares worth $131,509. $926,985 worth of stock was sold by Majoras Deborah P on Wednesday, August 29. Another trade for 3,081 shares valued at $276,951 was sold by Matthew Price. Another trade for 7,828 shares valued at $715,072 was made by Skoufalos Ioannis on Friday, November 9. On Friday, November 9 Bishop Steven D sold $9.54M worth of The Procter & Gamble Company (NYSE:PG) or 104,157 shares. Shares for $1.76 million were sold by Taylor David S.

More notable recent The Procter & Gamble Company (NYSE:PG) news were published by: Seekingalpha.com which released: “Procter & Gamble: Bucking The Market’s Plunge – Seeking Alpha” on December 17, 2018, also Streetinsider.com with their article: “Morgan Stanley Upgrades Procter & Gamble (PG) to Overweight – StreetInsider.com” published on December 13, 2018, Bizjournals.com published: “I Tried It: P&G’s new razor the best from Gillette yet – Cincinnati Business Courier” on December 18, 2018. More interesting news about The Procter & Gamble Company (NYSE:PG) were released by: Streetinsider.com and their article: “Procter & Gamble (PG) to Acquire People of Color-Focused Walker & Company Brands – StreetInsider.com” published on December 12, 2018 as well as Benzinga.com‘s news article titled: “Procter & Gamble (NYSE:PG) Is Beginning A Turnaround, BofA Says In Upgrade – Benzinga” with publication date: December 13, 2018.

Investors sentiment increased to 0.79 in 2018 Q3. Its up 0.01, from 0.78 in 2018Q2. It increased, as 37 investors sold PG shares while 756 reduced holdings. 139 funds opened positions while 490 raised stakes. 1.41 billion shares or 1.36% less from 1.43 billion shares in 2018Q2 were reported. Alphamark Advsrs Lc holds 1.88% of its portfolio in The Procter & Gamble Company (NYSE:PG) for 56,204 shares. Baxter Bros reported 62,394 shares stake. Massachusetts-based Cape Cod Five Cents Bancorporation has invested 0.95% in The Procter & Gamble Company (NYSE:PG). First Republic Investment Management has invested 0.68% in The Procter & Gamble Company (NYSE:PG). Lau Assocs Ltd Llc stated it has 1.63% of its portfolio in The Procter & Gamble Company (NYSE:PG). Bb&T Limited Co reported 630,626 shares. Bridgewater Assocs Limited Partnership holds 0.02% of its portfolio in The Procter & Gamble Company (NYSE:PG) for 28,325 shares. The Sweden-based Nordea Investment Mngmt has invested 0.18% in The Procter & Gamble Company (NYSE:PG). Gladius Management Ltd Partnership stated it has 0% in The Procter & Gamble Company (NYSE:PG). James Invest Rech stated it has 470 shares or 0% of all its holdings. Hillsdale Invest Mgmt invested in 50 shares or 0% of the stock. Stonebridge Cap Lc owns 2.25% invested in The Procter & Gamble Company (NYSE:PG) for 134,238 shares. Peddock Capital Advisors Limited Liability Com reported 0.48% of its portfolio in The Procter & Gamble Company (NYSE:PG). Moreover, Uss Mgmt Ltd has 0.11% invested in The Procter & Gamble Company (NYSE:PG). 12,396 are held by New England Research And Management Incorporated.

Analysts await The Procter & Gamble Company (NYSE:PG) to report earnings on January, 23 before the open. They expect $1.21 EPS, up 1.68% or $0.02 from last year’s $1.19 per share. PG’s profit will be $3.01B for 18.84 P/E if the $1.21 EPS becomes a reality. After $1.12 actual EPS reported by The Procter & Gamble Company for the previous quarter, Wall Street now forecasts 8.04% EPS growth.

Among 25 analysts covering Proctor & Gamble (NYSE:PG), 10 have Buy rating, 1 Sell and 14 Hold. Therefore 40% are positive. Proctor & Gamble had 106 analyst reports since August 4, 2015 according to SRatingsIntel. The stock of The Procter & Gamble Company (NYSE:PG) has “Neutral” rating given on Wednesday, March 30 by B. Riley & Co. UBS maintained it with “Neutral” rating and $84 target in Wednesday, January 27 report. Jefferies maintained the shares of PG in report on Thursday, August 17 with “Buy” rating. Bank of America maintained it with “Buy” rating and $90 target in Thursday, April 12 report. The firm has “Hold” rating by SunTrust given on Thursday, October 5. The stock of The Procter & Gamble Company (NYSE:PG) earned “Buy” rating by Citigroup on Thursday, August 4. The firm has “Sector Perform” rating given on Tuesday, October 27 by RBC Capital Markets. Deutsche Bank maintained The Procter & Gamble Company (NYSE:PG) rating on Wednesday, August 1. Deutsche Bank has “Hold” rating and $84 target. The stock of The Procter & Gamble Company (NYSE:PG) has “Hold” rating given on Friday, April 20 by Deutsche Bank. As per Wednesday, October 26, the company rating was maintained by B. Riley & Co.

Investors sentiment decreased to 0.85 in 2018 Q3. Its down 0.23, from 1.08 in 2018Q2. It fall, as 41 investors sold TMO shares while 434 reduced holdings. 111 funds opened positions while 295 raised stakes. 333.46 million shares or 0.38% more from 332.19 million shares in 2018Q2 were reported. 333,782 are held by Chevy Chase Tru. Appleton Prtn Ma owns 51,072 shares. Franklin Street Advsrs Nc holds 22,629 shares. Mutual Of America Mngmt Llc stated it has 52,024 shares or 0.18% of all its holdings. Eaton Vance Management holds 486,800 shares. Axiom Int Lc De owns 85,013 shares. Atlanta Capital Management L L C holds 849,026 shares. Blair William Il holds 0.21% of its portfolio in Thermo Fisher Scientific Inc. (NYSE:TMO) for 140,388 shares. Inverness Counsel Ltd New York holds 0.7% or 54,184 shares. Amp Cap Limited holds 0.24% or 177,454 shares. Veritas Ltd Liability Partnership invested in 9.81% or 381,134 shares. Aviance Capital Partners owns 9,206 shares. Shapiro Cap Llc holds 0% of its portfolio in Thermo Fisher Scientific Inc. (NYSE:TMO) for 2,190 shares. Trust Company Of Oklahoma holds 10,461 shares or 0% of its portfolio. Renaissance Investment Ltd reported 44,659 shares.

Bradley Foster & Sargent Inc, which manages about $2.48B and $2.95B US Long portfolio, decreased its stake in Metlife Inc (NYSE:MET) by 35,112 shares to 80,408 shares, valued at $3.76M in 2018Q3, according to the filing. It also reduced its holding in Chubb Ltd by 4,977 shares in the quarter, leaving it with 163,352 shares, and cut its stake in Novartis A G Adr (NYSE:NVS).

Among 20 analysts covering Thermo Fisher Scientific (NYSE:TMO), 17 have Buy rating, 0 Sell and 3 Hold. Therefore 85% are positive. Thermo Fisher Scientific had 74 analyst reports since July 24, 2015 according to SRatingsIntel. The stock of Thermo Fisher Scientific Inc. (NYSE:TMO) has “Overweight” rating given on Thursday, February 1 by Morgan Stanley. The rating was maintained by Cowen & Co on Wednesday, October 25 with “Buy”. Deutsche Bank maintained the stock with “Buy” rating in Thursday, October 26 report. The firm earned “Overweight” rating on Thursday, October 25 by Morgan Stanley. The firm has “Buy” rating given on Friday, July 22 by BTIG Research. The rating was initiated by JP Morgan with “Overweight” on Thursday, September 22. The stock has “Hold” rating by Jefferies on Tuesday, June 6. Mizuho maintained the stock with “Buy” rating in Friday, May 27 report. The rating was maintained by Cowen & Co on Friday, September 8 with “Buy”. Cowen & Co maintained Thermo Fisher Scientific Inc. (NYSE:TMO) rating on Wednesday, October 11. Cowen & Co has “Buy” rating and $220.0 target.

More notable recent Thermo Fisher Scientific Inc. (NYSE:TMO) news were published by: Seekingalpha.com which released: “Thermo Fisher – Fishing For Cash – Seeking Alpha” on January 11, 2018, also Seekingalpha.com with their article: “Can Thermo Fisher Ride The Pharma And Biotech Wave? – Seeking Alpha” published on May 21, 2018, Seekingalpha.com published: “Thermo Fisher launches Ion AmpliSeq HD technology – Seeking Alpha” on June 18, 2018. More interesting news about Thermo Fisher Scientific Inc. (NYSE:TMO) were released by: Seekingalpha.com and their article: “Thermo Fisher CE marks Oncomine Dx target test – Seeking Alpha” published on October 17, 2018 as well as Benzinga.com‘s news article titled: “Thermo Fisher Scientific Inc (NYSE:TMO) – Q3 Earnings Preview: Thermo Fisher Scientific – Benzinga” with publication date: October 23, 2018.

Since October 1, 2018, it had 0 insider purchases, and 5 selling transactions for $39.04 million activity. 17,235 shares were sold by Herrema Gregory J., worth $4.26M. $2.29M worth of Thermo Fisher Scientific Inc. (NYSE:TMO) shares were sold by Williamson Stephen. 125,520 shares were sold by CASPER MARC N, worth $31.07 million.

The Procter & Gamble Company (NYSE:PG) Institutional Positions Chart